» Articles » PMID: 28018580

Engineering of Brome Mosaic Virus for Biomedical Applications

Overview
Journal RSC Adv
Specialty Chemistry
Date 2016 Dec 27
PMID 28018580
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

Viral nanoparticles (VNPs) are becoming versatile tools in platform technology development. Their well-defined structures as well as their programmability through chemical and genetic modification allow VNPs to be engineered for potential imaging and therapeutic applications. In this article, we report the application of a variety of bioconjugation chemistries to the plant VNP (BMV). Functional BMV nanoparticles displaying multiple copies of fluorescent dyes, PEG molecules, chemotherapeutic drug moieties, targeting proteins and cell penetrating peptides were formulated. This opens the door for the application of BMV in nanomedicine.

Citing Articles

Challenges and prospects in geriatric epilepsy treatment: the role of the blood-brain barrier in pharmacotherapy and drug delivery.

Chen X, Luo J, Song M, Pan L, Qu Z, Huang B Front Aging Neurosci. 2024; 16:1342366.

PMID: 38389560 PMC: 10882099. DOI: 10.3389/fnagi.2024.1342366.


The diversity of protein-protein interaction interfaces within T=3 icosahedral viral capsids.

Prakash D, Gosavi S Front Mol Biosci. 2022; 9:967877.

PMID: 36339706 PMC: 9631432. DOI: 10.3389/fmolb.2022.967877.


Gelatin-methacryloyl hydrogels containing turnip mosaic virus for fabrication of nanostructured materials for tissue engineering.

Gonzalez-Gamboa I, Velazquez-Lam E, Lobo-Zegers M, Frias-Sanchez A, Tavares-Negrete J, Monroy-Borrego A Front Bioeng Biotechnol. 2022; 10:907601.

PMID: 36118588 PMC: 9480610. DOI: 10.3389/fbioe.2022.907601.


Subset of Fluorophores Is Responsible for Radiation Brightening in Viromimetic Particles.

Sushma A, Zhao B, Tsvetkova I, Perez-Segura C, Hadden-Perilla J, Reilly J J Phys Chem B. 2021; 125(37):10494-10505.

PMID: 34507491 PMC: 9009136. DOI: 10.1021/acs.jpcb.1c06395.


Strategies for delivering therapeutics across the blood-brain barrier.

Terstappen G, Meyer A, Bell R, Zhang W Nat Rev Drug Discov. 2021; 20(5):362-383.

PMID: 33649582 DOI: 10.1038/s41573-021-00139-y.


References
1.
Destito G, Yeh R, Rae C, Finn M, Manchester M . Folic acid-mediated targeting of cowpea mosaic virus particles to tumor cells. Chem Biol. 2007; 14(10):1152-62. PMC: 2293326. DOI: 10.1016/j.chembiol.2007.08.015. View

2.
Wang Q, Lin T, Johnson J, Finn M . Natural supramolecular building blocks. Cysteine-added mutants of cowpea mosaic virus. Chem Biol. 2002; 9(7):813-9. DOI: 10.1016/s1074-5521(02)00166-7. View

3.
Singh P, Prasuhn D, Yeh R, Destito G, Rae C, Osborn K . Bio-distribution, toxicity and pathology of cowpea mosaic virus nanoparticles in vivo. J Control Release. 2007; 120(1-2):41-50. PMC: 2849971. DOI: 10.1016/j.jconrel.2007.04.003. View

4.
Udit A, Brown S, Baksh M, Finn M . Immobilization of bacteriophage Qbeta on metal-derivatized surfaces via polyvalent display of hexahistidine tags. J Inorg Biochem. 2008; 102(12):2142-6. DOI: 10.1016/j.jinorgbio.2008.08.003. View

5.
Sun J, Dufort C, Daniel M, Murali A, Chen C, Gopinath K . Core-controlled polymorphism in virus-like particles. Proc Natl Acad Sci U S A. 2007; 104(4):1354-9. PMC: 1783121. DOI: 10.1073/pnas.0610542104. View